Last Thursday, Matt brought you Part I of his health care-related podcast. Today he brings you Part II, and as promised, this episode of Making Money With Matt McCall is dedicated to the industry’s investment potential.
Drug discovery is an expensive business with a low success rate. But thanks to artificial intelligence (“AI”), that’s about to change. This next-generation technology will help streamline the drug-discovery process. So Matt highlights four companies leading the charge in this cutting-edge trend. They’re high-risk but could pay off big over the long term.
Click Here to Get Matt’s Free Report: www.HiddenSector2023.com
#investing #artificialintelligence #health
00:00 AI in Drug Discovery
3:58 Current Drug Development Process
7:51 Schrodinger (SDGR)
11:46 Exscientia (EXAI)
13:35 Recursion Pharmaceuticals (RXRX)
15:41 Relay Therapeutics (RLAY
➡️ Follow us on Facebook: https://www.facebook.com/StansberryResearch
➡️ Follow us on Twitter: https://twitter.com/stansberry
➡️ Follow us on Instagram: https://www.instagram.com/stansberry_research
➡️ Follow us on LinkedIn: https://www.linkedin.com/company/stanberry-research
